Editorial Comment on “Quantitative Assessment of Additive Effects of Mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study”

Posted by author-avatar

Publication date: September 2026

Source: Urology, Volume 215

Author(s): Hann-Chorng Kuo

Read More

Newer
Editorial Comment on “Vaginal Estrogen Prescription is Associated With Reduced Rates of Serious Adverse Outcomes in Women of all Age Groups With Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis”
Older Longitudinal Evolution of Uroflowmetry Patterns From Childhood to Puberty After Hypospadias Repair: A 12-Year Cohort Study